menu
    • menu

    Company profile for Organovo Holdings

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We are striving to change the face of medicine through clinical development of regenerative medicine therapies for treating disease and by enabling translational drug discovery. With decades of leadership experience in the life science indus...
    We are pioneering a unique set of therapeutic and drug profiling capabilities based on our revolutionary ability to 3D bioprint tissues that mimic key aspects of human biology and disease. We are striving to change the face of medicine through clinical development of regenerative medicine therapies for treating disease and by enabling translational drug discovery. With decades of leadership experience in the life science industry, our team fosters an ethos of innovation to develop regenerative medicine therapies aimed at treating a range of serious liver diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Organovo HoldingsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6275 Nancy Ridge Drive, Suite 110 San Diego, CA 92121
    Telephone
    Telephone
    (858) 224-1000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://organovo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/organovo-inc-
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    VivoSim to Carry Forward Organovo 3D Bioprinting
    VivoSim to Carry Forward Organovo 3D Bioprinting

    23 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/23/3066354/37000/en/VivoSim-to-Carry-Forward-Organovo-3D-Bioprinting.html

    GLOBENEWSWIRE
    23 Apr 2025
    Share Share
    Organovo Updates Cash and Nasdaq Listing Requirements
    Organovo Updates Cash and Nasdaq Listing Requirements

    02 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/02/3054219/37000/en/Organovo-Provides-Update-on-Cash-and-Nasdaq-Continued-Listing-Requirements.html

    GLOBENEWSWIRE
    02 Apr 2025
    Share Share
    Organovo Provides Business Update
    Organovo Provides Business Update

    27 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/27/3050513/37000/en/Organovo-Provides-Business-Update.html

    GLOBENEWSWIRE
    27 Mar 2025
    Share Share
    Organovo Sells FXR Program to Eli Lilly and Company
    Organovo Sells FXR Program to Eli Lilly and Company

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3048974/37000/en/Organovo-Announces-Close-of-the-Sale-of-FXR-Program-to-Eli-Lilly-and-Company.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Organovo Announces Reverse Stock Split
    Organovo Announces Reverse Stock Split

    19 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/19/3045352/37000/en/Organovo-Announces-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    19 Mar 2025
    Share Share
    Organovo Issues Additional Shares With Warrant Exercises
    Organovo Issues Additional Shares With Warrant Exercises

    06 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/06/3038164/37000/en/Organovo-Announces-the-Issuance-of-Additional-Shares-in-Conjunction-with-Warrant-Exercises.html

    GLOBENEWSWIRE
    06 Mar 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search